Irina Blumenstein

Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

Journal: Journal of Crohn's & colitis

Published: July 07, 2026

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

Journal: Journal of Crohn's & colitis

Published: July 01, 2026

Title Not Found

Title Not Found

Journal: Zeitschrift fur Gastroenterologie

Published: June 22, 2026

Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care

Version 7.0 of the S3 Guideline on Ulcerative Colitis sets out clearly defined treatment goals, an open treatment sequence, and a call for improved cross-sectoral care

Journal: Zeitschrift fur Gastroenterologie

Published: June 22, 2026

Updated S3 guideline on ulcerative colitis

Updated S3 guideline on ulcerative colitis

Journal: Zeitschrift fur Gastroenterologie

Published: June 22, 2026

New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC.

New Diagnostic Criteria for Acute Severe Ulcerative Colitis in the Modern Treatment Era: A Modified Delphi Consensus by REFINED-ASUC.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: May 11, 2026

Drug Persistence of Patients with Inflammatory Bowel Disease Under Biological Treatment in the Pre IL-23 Era in a Tertiary Referral Center in Germany.

Drug Persistence of Patients with Inflammatory Bowel Disease Under Biological Treatment in the Pre IL-23 Era in a Tertiary Referral Center in Germany.

Journal: Journal of clinical medicine

Published: October 07, 2025

Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study.

Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study.

Journal: The American journal of gastroenterology

Published: September 23, 2025

Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis.

Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis.

Journal: Biomedicines

Published: August 12, 2025

Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis.

Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis.

Journal: PloS one

Published: August 11, 2025

Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.

Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.

Journal: Journal of Crohn's & colitis

Published: July 24, 2025

Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.

Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age.

Journal: Inflammatory bowel diseases

Published: June 03, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026